BACKGROUND:Auricular acupuncture (AA) has been shown to alleviate acute and chronic pain. We investigated the effects of auricular electroacupuncture (AE) on pain and analgesic drug consumption in the first 48 h after unilateral mandibular third molar tooth extraction under local anesthesia in a prospective, randomized, double-blind, placebo-controlled study in 149 patients. METHODS: Patients received either AA with electrical stimulation (AE, n = 76) or without (AA, n = 37) electrical stimulation at an alternating frequency of 2/100 Hz or a sham AE with metal plates instead of needles and no electrical stimulation, no-needle (NN, n = 36) at the AA points 1 (tooth), 55 (Shen men) and 84 (mouth) during the entire study period. Regularly rated pain intensity (five-point verbal rating scale), consumption of acetaminophen 500 mg tablets and additional rescue medication with mefenamic acid 500 mg were assessed. RESULTS: The median fraction of time when pain was rated as moderate or worse (upper and lower quartile): AE: 33% (12%, 64%), AA: 22% (6%, 56%), NN: 30% (7%, 53%) did not differ significantly among the treatment groups. There were no significant differences in mean number of acetaminophen 500 mg tablets (range): AE: 5.2 (0-12), AA: 4.6 (0-11), NN: 5.4 (0-10) or percentage of patients requiring additional mefenamic acid: AE: 19%, AA: 18%, NN: 19%. CONCLUSION: We conclude that neither AE nor AA alone reduce either pain intensity or analgesic consumption in a molar tooth extraction model of acute pain.
RCT Entities:
BACKGROUND: Auricular acupuncture (AA) has been shown to alleviate acute and chronic pain. We investigated the effects of auricular electroacupuncture (AE) on pain and analgesic drug consumption in the first 48 h after unilateral mandibular third molar tooth extraction under local anesthesia in a prospective, randomized, double-blind, placebo-controlled study in 149 patients. METHODS:Patients received either AA with electrical stimulation (AE, n = 76) or without (AA, n = 37) electrical stimulation at an alternating frequency of 2/100 Hz or a sham AE with metal plates instead of needles and no electrical stimulation, no-needle (NN, n = 36) at the AA points 1 (tooth), 55 (Shen men) and 84 (mouth) during the entire study period. Regularly rated pain intensity (five-point verbal rating scale), consumption of acetaminophen 500 mg tablets and additional rescue medication with mefenamic acid 500 mg were assessed. RESULTS: The median fraction of time when pain was rated as moderate or worse (upper and lower quartile): AE: 33% (12%, 64%), AA: 22% (6%, 56%), NN: 30% (7%, 53%) did not differ significantly among the treatment groups. There were no significant differences in mean number of acetaminophen 500 mg tablets (range): AE: 5.2 (0-12), AA: 4.6 (0-11), NN: 5.4 (0-10) or percentage of patients requiring additional mefenamic acid: AE: 19%, AA: 18%, NN: 19%. CONCLUSION: We conclude that neither AE nor AA alone reduce either pain intensity or analgesic consumption in a molar tooth extraction model of acute pain.
Authors: Gary N Asher; Daniel E Jonas; Remy R Coeytaux; Aimee C Reilly; Yen L Loh; Alison A Motsinger-Reif; Stacey J Winham Journal: J Altern Complement Med Date: 2010-10 Impact factor: 2.579
Authors: Claire Shuiqing Zhang; Angela Weihong Yang; Anthony Lin Zhang; Brian H May; Charlie Changli Xue Journal: J Altern Complement Med Date: 2013-10-19 Impact factor: 2.579
Authors: Helene M Langevin; Rosa Schnyer; Hugh MacPherson; Robert Davis; Richard E Harris; Vitaly Napadow; Peter M Wayne; Ryan J Milley; Lixing Lao; Elisabet Stener-Victorin; Jiang-Ti Kong; Richard Hammerschlag Journal: J Altern Complement Med Date: 2015-02-24 Impact factor: 2.579
Authors: Helene M Langevin; Peter M Wayne; Hugh Macpherson; Rosa Schnyer; Ryan M Milley; Vitaly Napadow; Lixing Lao; Jongbae Park; Richard E Harris; Misha Cohen; Karen J Sherman; Aviad Haramati; Richard Hammerschlag Journal: Evid Based Complement Alternat Med Date: 2010-10-11 Impact factor: 2.629
Authors: Xian-Liang Liu; Jing-Yu Tan; Alex Molassiotis; Lorna K P Suen; Yan Shi Journal: Evid Based Complement Alternat Med Date: 2015-10-12 Impact factor: 2.629